Further in-depth investigations of the divergent molecular functions of MAP4K4 activity during onset and progression of brain tumors and neurodegeneration will be necessary to design disease-specific intervention strategies targeting differential MAP4K4 functions in these two disease entities. This evidence concerns the gene MAP4K4 and brain neoplasm.